A randomized comparison of chloroquine versus dihydroartemisinin-piperaquine for the treatment of Plasmodium vivax infection in Vietnam

A randomized comparison of chloroquine versus dihydroartemisinin-piperaquine for the treatment of Plasmodium vivax infection in Vietnam

Pokaż inne wersje (1)

A total of 128 Vietnamese patients with symptomatic Plasmodium vivax mono-infections were enrolled in a prospective, open-label, randomized trial to receive either chloroquine or dihydroartemisinin-piperaquine (DHA-PPQ). The proportions of patients with adequate clinical and parasitological response...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Thuan, PD, Ca, NTN, Toi, PV, Nhien, NTT, Thanh, NV, Anh, ND, Phu, NH, Thai, CQ, Thai, LH, Hoa, NT, Dong, LT, Loi, MA, Son, DH, Khanh, TTN, Dolecek, C, Nhan, HT, Wolbers, M, Thwaites, G, Farrar, J, White, NJ, Hien, TT
Format:	Journal article
Język:	English
Wydane:	American Society of Tropical Medicine and Hygiene 2016

Podobne zapisy

A randomized comparison of Chloroquine versus Dihydroartemisinin-Piperaquine for the treatment of Plasmodium vivax infection in Vietnam
od: Thuan, P, i wsp.
Wydane: (2016)

Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
od: Thanh, N, i wsp.
Wydane: (2017)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
od: Ashenafi Assefa, i wsp.
Wydane: (2022-12-01)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
od: Ashenaf Assefa, i wsp.
Wydane: (2023-04-01)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
od: Jean Popovici, i wsp.
Wydane: (2018-08-01)

Efficacy and safety of dihydroartemisinin-piperaquine.
od: Myint, H, i wsp.
Wydane: (2007)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
od: Phyo, A, i wsp.
Wydane: (2011)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
od: Awab, G, i wsp.
Wydane: (2010)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
od: Woodrow Charles J, i wsp.
Wydane: (2010-04-01)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
od: Phuc, B, i wsp.
Wydane: (2017)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
od: Bui Quang Phuc, i wsp.
Wydane: (2017-04-01)

Molecular markers of dihydroartemisinin-piperaquine resistance in northwestern Thailand
od: Khine Nwe Win, i wsp.
Wydane: (2022-11-01)

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
od: Tran, T, i wsp.
Wydane: (2004)

Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients
od: Wanting Wu, i wsp.
Wydane: (2021-02-01)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
od: Zongo, I, i wsp.
Wydane: (2014)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
od: Issaka Zongo, i wsp.
Wydane: (2014-01-01)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
od: Permala, J, i wsp.
Wydane: (2017)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
od: Chotsiri, P, i wsp.
Wydane: (2017)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
od: Rijken, M, i wsp.
Wydane: (2011)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
od: Tarning, J, i wsp.
Wydane: (2012)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
od: Poespoprodjo, JR, i wsp.
Wydane: (2014)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
od: Chotsiri, P, i wsp.
Wydane: (2019)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
od: Tarning, J, i wsp.
Wydane: (2012)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
od: Mytton, O, i wsp.
Wydane: (2007)

Observation of Malaria Treatment with Dihydroartemisinin-Piperaquine Combination at Primary Health Care
od: Lambok Siahaan
Wydane: (2022-06-01)

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
od: Benjamin Abuaku, i wsp.
Wydane: (2023-01-01)

Choreoathetosis – an unusual adverse effect of dihydroartemisinin-piperaquine: a case report
od: Benjamin Momo Kadia, i wsp.
Wydane: (2017-12-01)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
od: Palang Chotsiri, i wsp.
Wydane: (2019-01-01)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
od: Jeanne Rini Poespoprodjo, i wsp.
Wydane: (2014-01-01)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
od: Tarning, J, i wsp.
Wydane: (2008)

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.
od: Price, R, i wsp.
Wydane: (2007)

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial
od: Kamya, MR, i wsp.
Wydane: (2007)

Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
od: Abraham Rexford Oduro, i wsp.
Wydane: (2019-01-01)

Adherence to Dihydroartemisinin + Piperaquine Treatment Regimen in Low and High Endemic Areas in Indonesia
od: Irfanul Chakim, i wsp.
Wydane: (2022-01-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
od: Armedy Ronny Hasugian, i wsp.
Wydane: (2016-03-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
od: Armedy Ronny Hasugian, i wsp.
Wydane: (2016-03-01)

Pharmacokinetics of piperaquine and safety profile of dihydroartemisinin-piperaquine co-administered with antiretroviral therapy in malaria-uninfected HIV-positive Malawian adults
od: Banda, C, i wsp.
Wydane: (2018)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
od: Byakika-Kibwika, P, i wsp.
Wydane: (2019)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
od: Tarning, J, i wsp.
Wydane: (2007)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
od: Pauline Byakika-Kibwika, i wsp.
Wydane: (2019-12-01)